Fibroblast-specific TGF-β–Smad2/3 signaling underlies cardiac fibrosis
Open accessThe DOI matches its Crossref record; 63 of the 64 references it cites were found in a registry or an index.
Abstract
The master cytokine TGF-β mediates tissue fibrosis associated with inflammation and tissue injury. TGF-β induces fibroblast activation and differentiation into myofibroblasts that secrete extracellular matrix proteins. Canonical TGF-β signaling mobilizes Smad2 and Smad3 transcription factors that control fibrosis by promoting gene expression. However, the importance of TGF-β-Smad2/3 signaling in fibroblast-mediated cardiac fibrosis has not been directly evaluated in vivo. Here, we examined pressure overload-induced cardiac fibrosis in fibroblast- and myofibroblast-specific inducible Cre-expressing mouse lines with selective deletion of the TGF-β receptors Tgfbr1/2, Smad2, or Smad3. Fibroblast-specific deletion of Tgfbr1/2 or Smad3, but not Smad2, markedly reduced the pressure overload-induced fibrotic response as well as fibrosis mediated by a heart-specific, latency-resistant TGF-β mutant transgene. Interestingly, cardiac fibroblast-specific deletion of Tgfbr1/2, but not Smad2/3, attenuated the cardiac hypertrophic response to pressure overload stimulation. Mechanistically, loss of Smad2/3 from tissue-resident fibroblasts attenuated injury-induced cellular expansion within the heart and the expression of fibrosis-mediating genes. Deletion of Smad2/3 or Tgfbr1/2 from cardiac fibroblasts similarly inhibited the gene program for fibrosis and extracellular matrix remodeling, although deletion of Tgfbr1/2 uniquely altered expression of an array of regulatory genes involved in cardiomyocyte homeostasis and disease compensation. These findings implicate TGF-β-Smad2/3 signaling in activated tissue-resident cardiac fibroblasts as principal mediators of the fibrotic response.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Overexpression of SMAD3 enhances, whereas knockdown inhibits αSMA and extracellular matrix production in fibroblasts (45–48). Furthermore, fibroblast-specific deletion of SMAD3 reduces αSMA production and myofibroblast phenotype (49–52), for example, loss of SMAD3 lowers the number of activated myofibroblasts in cardiac fibrosis in vivo and reduces extracellular matrix production by myofibroblasts”
From Unraveling SSc Pathophysiology; The Myofibroblast (2018) · cites this paper as [47]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“By contrast, cultured human primary cardiac and dermal fibroblasts and immortalized cardiac fibroblasts were relatively poor models of human cardiac fibroblast diversity under resting or stimulated (TGFβ (refs. 19,39,40), IL-1β (ref. 41)) conditions.”
From Targeting immune–fibroblast cell communication in heart failure (2024) · cites this paper as [39]
The cited source says what the claim attributes to it.
In the citing paper
“TGF-β1 activates SMAD2/3 signaling, driving pro-fibrotic gene expression and extracellular matrix deposition in cardiac fibroblasts [85].”
From A Paradigm Shift: Arrhythmogenic Cardiomyopathy Is an Inflammatory Disease (2026) · cites this paper as [85]
The cited source says what the claim attributes to it.
In the citing paper
“In contrast, primary human cardiac fibroblasts, primary human dermal fibroblasts, and immortalized human cardiac fibroblasts were relatively poor models of human cardiac fibroblast diversity under resting or stimulated (TGFβ 20,33,34 , IL-1 β 35 ) conditions.”
From Targeting the Immune-Fibrosis Axis in Myocardial Infarction and Heart Failure (2022) · cites this paper as [33]
The cited source says what the claim attributes to it.
In the citing paper
“While numerous studies have implicated a role for TGFβ signaling in maladaptive cardiac remodeling and scar formation in HF 20,33”
From Targeting the Immune-Fibrosis Axis in Myocardial Infarction and Heart Failure (2022) · cites this paper as [33]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Heart Disease and Stroke Statistics—2017 Update: A Report From the American Heart Association
Benjamin, E. J., Blaha, M. J., Chiuve, S. E., Cushman, M., Das, S. R., Deo, R., de Ferranti, S. D., Floyd, J., Fornage, M., Gillespie, C., et al. (2017) · Circulation · doi:10.1161/cir.0000000000000485 · Cited by 12,591 · cited 1×
“Heart failure is an increasingly prevalent disease characterized by reduced cardiac output resulting from a progressive loss of cardiomyocytes, ventricular chamber remodeling, and accumulation of interstitial fibrosis (1).”
Smad-dependent and Smad-independent pathways in TGF-β family signalling
Derynck, R., & Zhang, Y. E. (2003) · Nature · doi:10.1038/nature02006 · Cited by 5,373
Nagueh, S. F., Smiseth, O. A., Appleton, C. P., Byrd, B. F., Dokainish, H., Edvardsen, T., Flachskampf, F. A., Gillebert, T. C., Klein, A. L., Lancellotti, P., et al. (2016) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2016.01.011 · Cited by 5,262
Cellular and molecular mechanisms of fibrosis
Wynn, T. (2008) · The Journal of Pathology · doi:10.1002/path.2277 · Cited by 4,495
TGF-β: the master regulator of fibrosis
Meng, X.-M., Nikolic-Paterson, D. J., & Lan, H. Y. (2016) · Nature Reviews Nephrology · doi:10.1038/nrneph.2016.48 · Cited by 3,528 · cited 1×
“Global TGF-β activity is upregulated in diseased hearts, where one of its primary actions is directed at the resident fibroblasts to alter the fibrotic response and ventricular remodeling (47, 48).”
Nagueh, S. F., Smiseth, O. A., Appleton, C. P., Byrd, B. F., Dokainish, H., Edvardsen, T., Flachskampf, F. A., Gillebert, T. C., Klein, A. L., Lancellotti, P., et al. (2016) · European Heart Journal – Cardiovascular Imaging · doi:10.1093/ehjci/jew082 · Cited by 2,425 · cited 1×
“The ratio of these measures ( E/e ′ ) was used as an indicator of diastolic function (60).”
Cardiac Fibroblast: The Renaissance Cell
Souders, C. A., Bowers, S. L. K., & Baudino, T. A. (2009) · Circulation Research · doi:10.1161/circresaha.109.209809 · Cited by 984 · cited 1×
“Progressive cardiac fibrosis in heart failure is predominantly mediated by the tissue-resident cardiac fibroblast, which becomes activated and then differentiated into a cell type referred to as the myofibroblast (5, 6).”
Transforming growth factor (TGF)-β signaling in cardiac remodeling
Dobaczewski, M., Chen, W., & Frangogiannis, N. G. (2011) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2010.10.033 · Cited by 934 · cited 1×
“TGF-β is considered a “master” cytokine/growth factor produced within injured or diseased tissues, where it activates fibroblasts and facilitates ECM production (15, 16).”
The role of TGF-β signaling in myocardial infarction and cardiac remodeling
BUJAK, M., & FRANGOGIANNIS, N. (2007) · Cardiovascular Research · doi:10.1016/j.cardiores.2006.10.002 · Cited by 927
Genetic lineage tracing defines myofibroblast origin and function in the injured heart
Kanisicak, O., Khalil, H., Ivey, M. J., Karch, J., Maliken, B. D., Correll, R. N., Brody, M. J., J. Lin, S.-C., Aronow, B. J., Tallquist, M. D., et al. (2016) · Nature Communications · doi:10.1038/ncomms12260 · Cited by 892 · cited 6×
“Hence, here we used mice in which the Postn genetic locus was targeted with a tamoxifen-inducible MerCreMer (MCM) cDNA (29), and these mice were crossed with Smad2 fl/fl , Smad3 fl/fl , Smad2/3 fl/fl , and Tgfbr1/2 fl/fl targeted mice (Figure 2A).”
InfluentialSelf-citation
Cited by
Items 101–200 of 925
Fibroblast contributions to ischemic cardiac remodeling
Burke, R. M., Villar, K. N. B., & Small, E. M. (2020) · Cellular Signalling · doi:10.1016/j.cellsig.2020.109824 · Cited by 81
Cardiac repair after myocardial infarction: A two-sided role of inflammation-mediated
Li, T., Yan, Z., Fan, Y., Fan, X., Li, A., Qi, Z., & Zhang, J. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.1077290 · Cited by 82
“In contrast, fibroblasts infected with Cre’s adenovirus block the expression of TGFbR1/2 or Smad3, leading to impaired transdifferentiation of this cell and thus attenuating cardiac fibrosis and ECM remodeling (52).”
BackgroundSIRT3 as a potential therapeutic target for heart failure
Chen, J., Chen, S., Zhang, B., & Liu, J. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105432 · Cited by 77
Evaluation of 6-PPD quinone toxicity on lung of male BALB/c mice by quantitative proteomics
He, W., Jie, C., Gu, A., & Wang, D. (2024) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2024.171220 · Cited by 74
Tuleta, I., Hanna, A., Humeres, C. D., Aguilan, J. T., Sidoli, S., Zhu, F., & Frangogiannis, N. G. (2024) · Cardiovascular Research · doi:10.1093/cvr/cvae210 · Cited by 80
Cho, N., Razipour, S. E., & McCain, M. L. (2018) · Experimental Biology and Medicine · doi:10.1177/1535370218761628 · Cited by 80
“For example, a-SMA expression decreased in cultured synovial fibroblasts after removal of exogenous TGF-b1.”
InfluentialResearch progress on drugs targeting the TGF-β signaling pathway in fibrotic diseases
Shi, N., Wang, Z., Zhu, H., Liu, W., Zhao, M., Jiang, X., Zhao, J., Ren, C., Zhang, Y., & Luo, L. (2022) · Immunologic Research · doi:10.1007/s12026-022-09267-y · Cited by 78
The role of macrophages in fibrosis of chronic kidney disease
Li, G., Yang, H., Zhang, D., Zhang, Y., Liu, B., Wang, Y.-X., Zhou, H., Xu, Z.-X., & Wang, Y. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.117079 · Cited by 84
Bastounis, E. E., Yeh, Y., & Theriot, J. A. (2019) · Scientific Reports · doi:10.1038/s41598-019-54336-2 · Cited by 77
Adding insult to injury - Inflammation at the heart of cardiac fibrosis
Smolgovsky, S. A., Ibeh, U., Tamayo, T. P., & Alcaide, P. (2020) · Cellular Signalling · doi:10.1016/j.cellsig.2020.109828 · Cited by 73
Bugg, D., Bretherton, R. C., Kim, P., Olszewski, E., Nagle, A., Schumacher, A. E., Chu, N., Gunaje, J. J., DeForest, C. A., Stevens, K. R., et al. (2020) · Circulation Research · doi:10.1161/circresaha.119.316162 · Cited by 72
GRK5 is a regulator of fibroblast activation and cardiac fibrosis
Eguchi, A., Coleman, R. C., Gresham, K. S., Gao, E., Ibetti, J., Chuprun, J. K., & Koch, W. J. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2012854118 · Cited by 69
“This amelioration of the cardiomyocyte hypertrophic response has also been previously reported in Tgfbr1/2 and Hsp47 deletion in fibroblasts (54, 55).”
Central role of cardiac fibroblasts in myocardial fibrosis of diabetic cardiomyopathy
Cheng, Y., Wang, Y., Yin, R., Xu, Y., Zhang, L., Zhang, Y., Yang, L., & Zhao, D. B. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1162754 · Cited by 75
Protease-activated receptor 2 deficiency mediates cardiac fibrosis and diastolic dysfunction
Friebel, J., Weithäuser, A., Witkowski, M., Rauch, B. H., Savvatis, K., Dörner, A., Tabaraie, T., Kašner, M., Moos, V., Bösel, D., et al. (2019) · European Heart Journal · doi:10.1093/eurheartj/ehz117 · Cited by 69
Roles of Biomarkers in Myocardial Fibrosis
Ding, Y., Wang, Y., Zhang, W., Jia, Q., Wang, X., Li, Y., Lv, S., & Zhang, J. (2020) · Aging and Disease · doi:10.14336/ad.2020.0604 · Cited by 75
“Smads TAC mice Cardiac tissues Smad3 or Smad2/3 deletion: cardiac fibrosis↓ [72]”
BackgroundFibroblast‐mediated intercellular crosstalk in the healthy and diseased heart
Nicin, L., Wagner, J. U. G., Luxán, G., & Dimmeler, S. (2021) · FEBS Letters · doi:10.1002/1873-3468.14234 · Cited by 79
Salib, C. G., Reina, N., Trousdale, W. H., Limberg, A. K., Tibbo, M. E., Jay, A. G., Robin, J. X., Turner, T. W., Jones, C. R., Paradise, C. R., et al. (2019) · Journal of Orthopaedic Research® · doi:10.1002/jor.24441 · Cited by 67
“Recent evidence suggests that the cellular transition from fibroblast to myofibroblast following injury may, in and of itself, promote further inflammation in the surrounding tissue.(7,14) Therefore, our study investigated whether upstream inhibition of the inflammatory cascade may alter myofibroblast activation and c…”
BackgroundXu, C., Hou, L., Zhao, J., Wang, Y., Jiang, F., Jiang, Q., Zhu, Z., & Tian, L. (2022) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2022.113302 · Cited by 70
Guo, X., Sunil, C., Adeyanju, O. A., Parker, A., Huang, S. K., Ikebe, M., Tucker, T. A., Idell, S., & Qian, G. (2022) · Scientific Reports · doi:10.1038/s41598-022-07044-3 · Cited by 69
Ding, J., Tang, Q., Luo, B., Zhang, L., Li, L., Han, L., Hao, M., Li, M., Yu, L., & Li, M. (2019) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2019.172549 · Cited by 65
Liu, X., Burke, R. M., Lighthouse, J. K., Baker, C. D., Dirkx, R. A., Kang, B., Chakraborty, Y., Mickelsen, D. M., Twardowski, J. J., Mello, S. S., et al. (2023) · Circulation Research · doi:10.1161/circresaha.121.320324 · Cited by 66
Targeting Sirtuin1 to treat aging-related tissue fibrosis: From prevention to therapy
Han, X., Ding, C., Sang, X., Peng, M., Yang, Q., Ning, Y., Lv, Q., Shan, Q., Hao, M., Wang, K.-L., et al. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.107983 · Cited by 72
Psarras, S., Beis, D., Nikouli, S., Tsikitis, M., & Capetanaki, Y. (2019) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2019.00032 · Cited by 70
“In addition to the well-known TGF-β contribution to cardiac fibrosis (93), recent important advances include IL-11 that induces fibrosis acting downstream of TGF-β (94) and the small proline-rich protein 2b that induces proliferation of mouse and human cardiac fibroblasts (95).”
BackgroundLi, R., & Frangogiannis, N. G. (2022) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2022.07.006 · Cited by 62
Ge, X., Meng, Q., Zhuang, R., Yuan, D., Liu, J., Lin, F., Fan, H., & Zhou, X. (2019) · International Journal of Cardiology · doi:10.1016/j.ijcard.2019.08.024 · Cited by 62
Zhang, X., Zheng, C., Gao, Z., Wang, L., Chen, C., Zheng, Y., & Meng, Y. (2021) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.17007 · Cited by 64
Mannino, F., Imbesi, C., Bitto, A., Minutoli, L., Squadrito, F., D’Angelo, T., Booz, C., Pallio, G., & Irrera, N. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114666 · Cited by 60
Myocardial fibrosis from the perspective of the extracellular matrix: Mechanisms to clinical impact
Lunde, I. G., Rypdal, K. B., Linthout, S. V., Díez, J., & González, A. (2024) · Matrix Biology · doi:10.1016/j.matbio.2024.08.008 · Cited by 68
Xu, Y., Ma, X., Ni, W., Zheng, L., Lin, Z., Lai, Y., Yang, N., Dai, Z., Teng, Y., Chen, Z., et al. (2024) · Advanced Science · doi:10.1002/advs.202406184 · Cited by 84
Defining the Cardiac Fibroblast Secretome in a Fibrotic Microenvironment
Ceccato, T. L., Starbuck, R. B., Hall, J., Walker, C. J., Brown, T. E., Killgore, J. P., Anseth, K. S., & Leinwand, L. A. (2020) · Journal of the American Heart Association · doi:10.1161/jaha.120.017025 · Cited by 60
Myofibroblast Deficiency of LSD1 Alleviates TAC-Induced Heart Failure
Huo, J., Jiao, L., An, Q., Chen, X., Qi, Y., Wei, B., Zheng, Y., Shi, X., Gao, E., Liu, H., et al. (2021) · Circulation Research · doi:10.1161/circresaha.120.318149 · Cited by 61
Fibroblasts orchestrate cellular crosstalk in the heart through the ECM
Bowers, S., Meng, Q., & Molkentin, J. D. (2022) · Nature Cardiovascular Research · doi:10.1038/s44161-022-00043-7 · Cited by 65
Self-citationSchips, T. G., Vanhoutte, D., Vo, A., Correll, R. N., Brody, M. J., Khalil, H., Karch, J. M., Tjondrokoesoemo, A., Sargent, M. A., Maillet, M., et al. (2019) · Nature Communications · doi:10.1038/s41467-018-08026-8 · Cited by 60
Self-citationUmbarkar, P., Ejantkar, S., Tousif, S., & Lal, H. (2021) · Cells · doi:10.3390/cells10092412 · Cited by 61
Yamada, Y., Sadahiro, T., Nakano, K., Honda, S., Abe, Y., Akiyama, T., Fujita, R., Nakamura, M., Maeda, T., Kuze, Y., et al. (2024) · Circulation · doi:10.1161/circulationaha.123.067504 · Cited by 59
Mefunidone ameliorates diabetic kidney disease in STZ and db/db mice
Jiang, Y., Xie, F., Lv, X., Wang, S., Liao, X., Yu, Y., Dai, Q., Zhang, Y., Meng, J., Hu, G., et al. (2020) · The FASEB Journal · doi:10.1096/fj.202001138rr · Cited by 58
Li, C., Meng, X., Wang, L., & Dai, X. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1092148 · Cited by 74
“Moreover, Smad3 can specifically reduce myocardial collagen content by inducing fibroblasts, thus being conductive to maintaining the ECM synthesis in the heart (Khalil et al., 2017).”
BackgroundInfluentialNovel use for old drugs: The emerging role of artemisinin and its derivatives in fibrosis
Wang, Y., Wang, Y., You, F., & Xue, J. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.104829 · Cited by 60
Horii, Y., Matsuda, S., Toyota, C., Morinaga, T., Nakaya, T., Tsuchiya, S., Ohmuraya, M., Hironaka, T., Yoshiki, R., Kasai, K., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-36189-6 · Cited by 62
Cardiac Fibrosis and Cardiac Fibroblast Lineage-Tracing: Recent Advances
Fu, X., Liu, Q., Li, C., Li, Y., & Wang, L. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00416 · Cited by 62
“Cre lines used Genes deleted or overexpressed Injury model Changes in cardiac fibroblasts Impact on cardiac function and phenotype References Tcf21-MerCreMer; Postn-MerCreMer Tgfbr1/2 double deletion; Smad2/3 single and double deletion TAC Reduced myofibroblast proliferation, differentiation, contraction, and ECM prot…”
BackgroundMethodInfluentialSelf-citationMiyazawa, K., Itoh, Y., Fu, H., & Miyazono, K. (2024) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2024.107256 · Cited by 60
FGF23 regulates atrial fibrosis in atrial fibrillation by mediating the STAT3 and SMAD3 pathways
Dong, Q., Li, S., Wang, W., Han, L., Xia, Z., Wu, Y., Tang, Y., Li, J., & Cheng, X. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.28548 · Cited by 60
“Many studies have confirmed that the SMAD3 signaling pathway plays a leading role in fibrosis mediated by CFs (Biernacka et al., 2015; Khalil et al., 2017).”
BackgroundDiverse origins and activation of fibroblasts in cardiac fibrosis
Aujla, P. K., & Kassiri, Z. (2020) · Cellular Signalling · doi:10.1016/j.cellsig.2020.109869 · Cited by 60
Mesenchymal Stem Cells Therapies on Fibrotic Heart Diseases
Gubert, F., da Silva, J. S., Vasques, J. F., de Jesus Gonçalves, R. G., Martins, R. S., de Sá, M. P. L., Mendez-Otero, R., & Zapata-Sudo, G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22147447 · Cited by 53
Signaling Pathways and Potential Therapeutic Strategies in Cardiac Fibrosis
Foucault‐Bertaud, A., Joshkon, A., Heim, X., Bachelier, R., Bardin, N., Leroyer, A. S., & Blot‐Chabaud, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24021756 · Cited by 56
Hall, C., Law, J. P., Reyat, J. S., Cumberland, M. J., Hang, S., Vo, N. T. N., Raniga, K., Weston, C. J., O’Shea, C., Townend, J., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-39369-y · Cited by 61
Tsai, T., Lin, C.-J., Hang, C., & Chen, W. (2019) · Cells · doi:10.3390/cells8080865 · Cited by 56
“The primary mouse cardiac fibroblasts were isolated from a pathogen-free neonate C57BL/6 mouse and cultured on pre-coated gelatin-based culture dishes as described in the previous study [31].”
MethodDaud, E., Ertracht, O., Bandel, N., Moady, G., Shehadeh, M., Reuveni, T., & Atar, S. (2021) · Cardiovascular Diabetology · doi:10.1186/s12933-021-01322-6 · Cited by 53
“Deposition of extracellular proteins, the cornerstone of fibrosis, is a combined and multistep process, involving, pro-inflammatory cytokines such as TGF-β1 and its down-stream effector Smad3 [8, 9].”
BackgroundCardiomyocyte SMAD4-Dependent TGF-β Signaling is Essential to Maintain Adult Heart Homeostasis
Umbarkar, P., Singh, A. P., Gupte, M., Verma, V. K., Galindo, C. L., Guo, Y., Zhang, Q., McNamara, J. W., Force, T. L., & Lal, H. (2019) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2018.10.003 · Cited by 62
Meng, Q., Bhandary, B., Bhuiyan, M. S., James, J., Osińska, H. E., Valiente-Alandí, Í., Shay‐Winkler, K., Gulick, J. M., Molkentin, J. D., Blaxall, B. C., et al. (2018) · Circulation Research · doi:10.1161/circresaha.118.313089 · Cited by 53
Self-citationReese‐Petersen, A. L., Olesen, M. S., Karsdal, M. A., Svendsen, J. H., & Genovese, F. (2020) · Matrix Biology · doi:10.1016/j.matbio.2020.03.005 · Cited by 53
Gut Microbiome and Organ Fibrosis
Costa, C. F. F. A., Sampaio‐Maia, B., Araújo, R., Nascimento, D. S., Ferreira‐Gomes, J., Pestana, M., Azevedo, M. J., & Alencastre, I. S. (2022) · Nutrients · doi:10.3390/nu14020352 · Cited by 57
Wang, Y., Wang, J., Liu, C., Li, J., Lu, K., Yu, Q., Zhang, Y., & Shen, Z. (2023) · Journal of Material Science and Technology · doi:10.1016/j.jmst.2023.06.005 · Cited by 51
Zeigler, A. C., Nelson, A. R., Chandrabhatla, A. S., Brazhkina, O., Holmes, J. W., & Saucerman, J. J. (2020) · Matrix Biology · doi:10.1016/j.matbio.2020.03.007 · Cited by 53
Berezin, A. Е., & Berezin, A. A. (2020) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2020.00047 · Cited by 53
Heart failure promotes multimorbidity through innate immune memory
Nakayama, Y., Fujiu, K., Oshima, T., Matsuda, J., Sugita, J., Matsubara, T. J., Liu, Y., Goto, K., Kani, K., Uchida, R., et al. (2024) · Science Immunology · doi:10.1126/sciimmunol.ade3814 · Cited by 54
“…TGF-β supplementation suppressed TAC-induced hematopoiesis, we have been unable to assess the cardiac consequences of rescuing TGF-β signaling in BM because TGF-β promotes fibrosis in multiple organs, including the heart ( 56 ), and approaches to deliver TGF-β specifically to BM remain limited.”
BackgroundMa, H., Yu, S., Liu, X., Zhang, Y., Fakadej, T., Liu, Z., Yin, C., Shen, W., Locasale, J. W., Taylor, J. M., et al. (2019) · Circulation · doi:10.1161/circulationaha.118.037803 · Cited by 51
Bano, A., Chaker, L., Muka, T., Mattace-Raso, F. U. S., Bally, L., Franco, O. H., Peeters, R. P., & Razvi, S. (2020) · Thyroid · doi:10.1089/thy.2019.0572 · Cited by 58
“Subclinical Hashimoto‡ Biochemical,* no thyroid medications, no thyroid surgery T1mapping T1-LV, 48 (13-83)”
BackgroundLiu, Y., Xu, J., Wu, M., Kang, L., & Xu, B. (2020) · Journal of Cellular Physiology · doi:10.1002/jcp.29732 · Cited by 56
“…J. H. Wang et al., 2016), inflammatory response and oxidative stress (Detterich, 2017; Suthahar, Meijers, Sillje, & de Boer, 2017), various cytokines (Khalil et al., 2017; Souza et al., 2017; Steele et al., 2017; M. Zhang, Ai, Mei, Hu, & Zhang, 2017), gas signaling molecules, autophagy (Song et…”
Pathogenic Mechanisms of Hypertrophic Cardiomyopathy beyond Sarcomere Dysfunction
Chou, C., & Chin, M. T. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22168933 · Cited by 52
Sun, C., Tian, X., Jia, Y., Yang, M., Li, Y., & Fernig, D. G. (2022) · Open Biology · doi:10.1098/rsob.210356 · Cited by 53
“Deletion of Smad3 reduces collagen deposition in the infarcted heart, indicating the regulation of TGF-β1/Smad signalling on fibrosis [28,29,33,34].”
BackgroundVistnes, M. (2024) · Pharmaceuticals · doi:10.3390/ph17030267 · Cited by 55
“Furthermore, the fibroblast-specific deletion of Smad3 greatly reduced fibrosis in response to aortic banding [30], and Smad3 deficiency protected against fibrosis in diabetic mice [78].”
BackgroundSakata, K., Bradley, R. P., Prakosa, A., Pinto, C. Y. A., Ali, S. Y., Loeffler, S., Tice, B. M., Boyle, P. M., Kholmovski, E. G., Yadav, R., et al. (2024) · Nature Cardiovascular Research · doi:10.1038/s44161-024-00489-x · Cited by 53
“This result has important implications, as the LA is often ablated for substrate modification 7,16–18, 25 , which , according to”
Fibroblast Smad7 Induction Protects the Remodeling Pressure-Overloaded Heart
Humeres, C. D., Shinde, A. V., Tuleta, I., Hernández, S. C., Hanna, A., Huang, S., Venugopal, H., Aguilan, J. T., Conway, S. J., Sidoli, S., et al. (2024) · Circulation Research · doi:10.1161/circresaha.123.323360 · Cited by 51
“6 9 There is a need to understand the negative regulatory mechanisms that inhibit fibroblast activity, preventing excessive, prolonged, or inappropriate activation and protecting from fibrosis progression and functional decompensation.”
Ma, S., Guo, Z., Liu, F.-Y., Hasan, S.-G., Yang, D., Tang, N., An, P., Wang, M., Wu, H., Yang, Z., et al. (2021) · Acta Pharmacologica Sinica · doi:10.1038/s41401-020-00587-z · Cited by 49
IGF-1 protects against angiotensin II-induced cardiac fibrosis by targeting αSMA
Ock, S., Ham, W., Kang, C. W., Kang, H., Lee, W. S., & Kim, J. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-03965-5 · Cited by 49
“Notably, cardiac fibroblast-specific deletion of Smad3 but not Smad2 significantly attenuates the cardiac fibrotic response to pressure overload [34].”
BackgroundCardioprotective effects of nanoceria in a murine model of cardiac remodeling
Kumari, P., Saifi, M. A., Khurana, A., & Godugu, C. (2018) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2018.07.011 · Cited by 49
Wang, D., Zhu, Z., Fu, Y., Zhang, Q., Zhang, Y., Wang, T., Weng, Y., Wen, Y., Cao, W., Tao, G., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.113090 · Cited by 49
Thbs1 regulates skeletal muscle mass in a TGFβ-Smad2/3-ATF4-dependent manner
Vanhoutte, D., Schips, T. G., Minerath, R. A., Huo, J., Kavuri, N. S. S., Prasad, V., Lin, S.-C., Bround, M. J., Sargent, M. A., Adams, C. M., et al. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.114149 · Cited by 52
“22,24,48,67 Similarly, Smad3 cDNA was amplified by PCR for insertion into the pShuttle-CMV vector (Agilent Technologies, Cat# 240007) to generate AdSmad3 according to the manufacturer’s instructions.”
MethodSelf-citationHydrogen Sulfide Ameliorates Homocysteine-Induced Cardiac Remodeling and Dysfunction
Kar, S., Shahshahan, H. R., Kambis, T. N., Yadav, S. K., Li, Z., Lefer, D. J., & Mishra, P. K. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.00598 · Cited by 48
Rypdal, K. B., Erusappan, P. M., Melleby, A. O., Seifert, D. E., Palmero, S., Strand, M. E., Tønnessen, T., Dahl, C. P., Almaas, V. M., Hubmacher, D., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-99032-2 · Cited by 48
Syed, A. M., Kundu, S., Ram, C., Kulhari, U., Kumar, A., Mugale, M. N., Mohapatra, P., Murty, U. S., & Sahu, B. D. (2022) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2022.04.019 · Cited by 48
Abe, H., Tanada, Y., Omiya, S., Podaru, M., Murakawa, T., Ito, J., Shah, A. M., Conway, S. J., Ono, M., & Otsu, K. (2021) · Science Signaling · doi:10.1126/scisignal.abe4932 · Cited by 48
Cardiac pericytes mediate the remodeling response to myocardial infarction
Quijada, P. J., Park, S., Zhao, P., Kolluri, K., Wong, D., Shih, K. D., Fang, K., Pezhouman, A., Wang, L., Daraei, A., et al. (2023) · Journal of Clinical Investigation · doi:10.1172/jci162188 · Cited by 51
“Their transition to a myofibroblast phenotype is primarily mediated by TGF-β signaling and Wnt/ β -catenin signaling (19–21).”
Cheng, X., Wang, L., Wen, X., Gao, L., Li, G., Chang, G., Qin, S., & Zhang, D. (2021) · EBioMedicine · doi:10.1016/j.ebiom.2021.103370 · Cited by 47
“The TGF-b1/Smads signaling pathway plays an important role in the activation of CFs [19,31].”
BackgroundChanges in cardiac resident fibroblast physiology and phenotype in aging
Trial, J., & Cieslik, K. A. (2018) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00237.2018 · Cited by 49
Vascular peroxidase 1 is a novel regulator of cardiac fibrosis after myocardial infarction
Liu, Z., Xu, Q., Yang, Q., Cao, J., Wu, C., Peng, H., Zhang, X., Chen, J., Cheng, G., Wu, Y., et al. (2019) · Redox Biology · doi:10.1016/j.redox.2019.101151 · Cited by 50
Zhang, X., Qu, H., Yang, T., Kong, X., & Zhou, H. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.112219 · Cited by 51
Sharma, N., Dev, R., Belenchia, A. M., Aroor, A. R., Whaley‐Connell, A. T., Pulakat, L., & Hans, C. P. (2019) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.118.311969 · Cited by 45
Huang, S., Chen, B., Humeres, C. D., Alex, L., Hanna, A., & Frangogiannis, N. G. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2020.118703 · Cited by 50
Macrophage‐fibroblast circuits in the spleen
Bellomo, A., Gentek, R., Golub, R., & Bajénoff, M. (2021) · Immunological Reviews · doi:10.1111/imr.12979 · Cited by 49
Li, N., Hang, W., Shu, H., & Zhou, N. (2022) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.17478 · Cited by 46
Su, Y., Zhang, W., Zhang, R., Yuan, Q., Wu, R., Liu, X., Wuri, J., Li, R., & Yan, T. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.870174 · Cited by 49
Katanasaka, Y., Yabe, H., Murata, N., Sobukawa, M., Sugiyama, Y., Sato, H., Honda, H., Sunagawa, Y., Funamoto, M., Shimizu, S., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-46711-z · Cited by 47
Xiao, M., Zhang, M., Bie, M., Wang, X., Guo, J., & Xiao, H. (2020) · Cardiology · doi:10.1159/000506072 · Cited by 48
The Impact of microRNAs in Renin–Angiotensin-System-Induced Cardiac Remodelling
Adamcová, M., Kawano, I., & Šimko, F. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094762 · Cited by 46
A concise discussion of the regulatory role of cGMP kinase I in cardiac physiology and pathology
Hofmann, F. B. (2018) · Basic Research in Cardiology · doi:10.1007/s00395-018-0690-1 · Cited by 46
Li, S., Sun, X., Wu, H., Yu, P., Wang, X., Jiang, Z., Gao, E., Chen, J., Li, D., Qiu, C., et al. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/6408352 · Cited by 43
Finke, D., Heckmann, M., Salatzki, J., Riffel, J., Herpel, E., Heinzerling, L., Meder, B., Völkers, M., Müller, O., Frey, N., et al. (2021) · Cancers · doi:10.3390/cancers13102498 · Cited by 44
Xue, Y., Zhang, M., Liu, M., Liu, Y., Li, L., Han, X., Sun, Z., & Chu, L. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.711701 · Cited by 45
Lin, C., Cheng, Y., Chen, H.-C., Chao, Y.-K., Nicholson, M. W., Yen, C.-L., Kamp, T. J., & Hsieh, P. C. H. (2022) · Theranostics · doi:10.7150/thno.76002 · Cited by 45
“In light of the finding that acetate and propionate inhibit TGF-β1 induced fibrogenesis, we further explored the canonical downstream SMAD2 phosphorylation which has been reported to upregulate α-SMA and COL1A1 expression in myofibroblasts and other cell types [42-44].”
BackgroundQian, C., Dong, G., Yang, C., Zheng, W., Zhong, C., Shen, Q., Lu, Y., & Zhao, Y. (2025) · Cell Communication and Signaling · doi:10.1186/s12964-025-02028-y · Cited by 51
“It has been increasingly recognized that phosphorylation of TGFβR1 driven by the increased Ser/Thr kinase activity of TGFβR2 tends to produce a docking site in the Gly/Ser-rich domain of TGFβR1, which results in the recruitment of the key transcription factors, including Smad2/3 [44, 45].”
Cardiac Fibrosis in Proteotoxic Cardiac Disease is Dependent Upon Myofibroblast TGF‐β Signaling
Bhandary, B., Meng, Q., James, J., Osińska, H. E., Gulick, J. M., Valiente-Alandí, Í., Sargent, M. A., Bhuiyan, M. S., Blaxall, B. C., Molkentin, J. D., et al. (2018) · Journal of the American Heart Association · doi:10.1161/jaha.118.010013 · Cited by 42
“In recent studies, a functional periostin allele driving tamoxifen (TAM)-inducible Cre recombinase expression whose transcriptional activity is largely restricted to activated myofibroblasts was validated and used to ablate TGF-b receptors 1 and 2 (TGF-br1 and 2, respectively) in those cells.(12,15,16) We used this lo…”
BackgroundMethodInfluentialSelf-citationJenke, A., Kistner, J., Saradar, S., Chekhoeva, A., Yazdanyar, M., Bergmann, A., Rötepohl, M. V., Lichtenberg, A., & Akhyari, P. (2020) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00651.2019 · Cited by 45
Dufeys, C., Daskalopoulos, E. P., Castanares‐Zapatero, D., Conway, S. J., Ginion, A., Bouzin, C., Ambroise, J., Bearzatto, B., Gala, J., Heymans, S. R. B., et al. (2021) · Basic Research in Cardiology · doi:10.1007/s00395-021-00846-y · Cited by 44
Endogenous Extracellular Matrix Regulates the Response of Osteosarcoma 3D Spheroids to Doxorubicin
Cortini, M., Macchi, F., Reggiani, F., Vitale, E., Lipreri, M. V., Perut, F., Ciarrocchi, A., Baldini, N., & Avnet, S. (2023) · Cancers · doi:10.3390/cancers15041221 · Cited by 46
Zhang, H., Caudle, Y., Shaikh, A., Yao, B., & Yin, D. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.04.092 · Cited by 41
Extracellular Vesicles as Therapeutic Agents for Cardiac Fibrosis
Rogers, R. G., Ciullo, A., Marbán, E., & Ibrahim, A. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00479 · Cited by 44
“…the most widely known macrophage-secreted cytokine to drive fibrosis is TGFβ, which binds to its cognate receptors on cardiac tissue (TGFβR2, ALK, and others) and mobilizes Smad2 and Smad3 transcription factors to initiate myofibroblast differentiation (Khalil et al., 2017; Pardali et al., 2017).”
BackgroundCrosstalk Between the Activated Slit2–Robo1 Pathway and TGF-β1 Signalling Promotes Cardiac Fibrosis
Liu, Y., Yin, Z., Xu, X., Liu, C., Duan, X., Song, Q., Tuo, Y., Wang, C., Yang, J., & Yin, S. (2020) · ESC Heart Failure · doi:10.1002/ehf2.13095 · Cited by 41
Gee, T. W., Richards, J. M. J., Mahmut, A., & Butcher, J. T. (2021) · Biomaterials · doi:10.1016/j.biomaterials.2021.120669 · Cited by 46
Metadata
- Authors
- Khalil, H., Kanisicak, O., Prasad, V., Correll, R. N., Fu, X., Schips, T., Vagnozzi, R. J., Liu, R., Huynh, T., Lee, S.-J., Karch, J., & Molkentin, J. D.
- Affiliations
- Cincinnati Children's Hospital Medical Center (US)
- Johns Hopkins University (US)
- Corresponding author
- Molkentin, Jeffery D.
- ORCID
- Venue
- Journal of Clinical Investigation
- Published
- 2017-09-11
- Volume
- 127
- Issue
- 10
- Pages
- 3770-3783
- ISSN
- 0021-9738 (ISSN-L)
- 1558-8238
- PMC
- PMC5617658
- OpenAlex
- W2750808153
- Cited by
- 905
- References
- 64
- Citations by year
- 2026: 92 · 2025: 102 · 2024: 128 · 2023: 121 · 2022: 144 · 2021: 110 · 2020: 84 · 2019: 85 · 2018: 34 · 2017: 2
- FWCI
- 43.33
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Civil War Book Review (submittedVersion)
- Language arts journal of Michigan (submittedVersion)
- Funders
- National Science Foundation
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (158486, 148429)
- National Institutes of Health
- National Heart, Lung, and Blood Institute (P01HL069779, R01HL105924)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01AR060636)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Congenital heart defects research
- Keywords
- myocardial fibrosis, TGF-beta signaling, Smad2, Smad3, cardiac fibroblasts, myofibroblasts, TGF-beta receptor, pressure overload, cardiac hypertrophy, extracellular matrix remodeling
- MeSH terms
- Receptor, Transforming Growth Factor-beta Type I, Receptor, Transforming Growth Factor-beta Type II, Animals, Fibrosis, Heart Diseases, Male, Mice, Transgenic, Myocardium, Organ Specificity, Signal Transduction, Transforming Growth Factor beta, Protein Serine-Threonine Kinases, Gene Deletion, Receptors, Transforming Growth Factor beta, Myocytes, Cardiac, Mice, Smad2 Protein, Smad3 Protein, Myofibroblasts
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.